Increased Intraepidermal Nerve Fiber Degeneration and Impaired Regeneration Relate to Symptoms and Deficits in Parkinson's Disease

Previous studies have shown cutaneous small fiber pathology in patients with Parkinson's disease (PD). These studies have focused on nerve degeneration, but recent reports suggest that nerve regeneration may also be important in PD pathology. To establish the extent of intraepidermal nerve fibe...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neurology Vol. 10; p. 111
Main Authors Jeziorska, Maria, Atkinson, Andrew, Kass-Iliyya, Lewis, Javed, Saad, Kobylecki, Christopher, Gosal, David, Marshall, Andrew, Silverdale, Monty, Malik, Rayaz A
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 14.02.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Previous studies have shown cutaneous small fiber pathology in patients with Parkinson's disease (PD). These studies have focused on nerve degeneration, but recent reports suggest that nerve regeneration may also be important in PD pathology. To establish the extent of intraepidermal nerve fiber (IENF) degeneration and regeneration and its relationship to clinical and neurological deficits in Parkinson's disease (PD). Twenty-three PD patients and 10 age-matched controls underwent skin biopsy and assessment of somatic and autonomic symptoms and deficits. We have assessed Intraepidermal Nerve Fiber Density (IENFD) using standard PGP9.5 staining and GAP-43 to assess Mean Axonal Length (MAL) and Intraepidermal Total Nerve Fiber Length (IETNFL). IENFD ( < 0.0001), MAL ( < 0.0001), IETNFL/Area ( = 0.009), and IETNFL/Length ( = 0.04) were significantly reduced in patients with PD compared to controls. IENFD correlated significantly with disease duration ( = 0.03), cumulative levodopa dose ( = 0.02), Unified Parkinson's Disease Rating Scale, Part III (UPDRS-III) ( = 0.01), Schwab and England Activities of Daily Living (ADL) ( = 0.03), NSP ( = 0.03), and 30:15 ratio ( = 0.03). IETNFL/Area correlated with the Autonomic Scale for Outcomes in Parkinson's Disease (SCOPA-AUT) ( = 0.03) and Diabetic Neuropathy Symptom score (DNS) ( = 0.04) and IETNFL/Length correlated with DNS ( = 0.03). MAL correlated with SCOPA-AUT ( = 0.01), DNS ( = 0.02), and DB-HRV ( = 0.02). Increased IENF degeneration and impaired regeneration correlates with somatic and autonomic symptoms and deficits in patients with PD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Giorgia Melli, Neurocenter of Southern Switzerland (NSI), Switzerland; Antonella Conte, Sapienza University of Rome, Italy
This article was submitted to Movement Disorders, a section of the journal Frontiers in Neurology
Edited by: Alain Kaelin-Lang, Neurocenter of Southern Switzerland (NSI), Switzerland
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2019.00111